Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activityLeslie W. Tari, John Finn, Daniel C. Bensen et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 118
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial AgentsLeslie W. Tari, John Finn, Felice C. Lightstone et al.|PLoS ONE|2013Cited by 104
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activityMicheal Trzoss, Leslie W. Tari, Felice C. Lightstone et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 81
Distinguishing On-Target versus Off-Target Activity in Early Antibacterial Drug Discovery Using a Macromolecular Synthesis AssayMark L. Cunningham, Karen Joy Shaw, Kirk Nelson et al.|SLAS DISCOVERY|2013Cited by 39